Charles River Laboratories | CRL - بدهی های جاری

قیمت سهام
173.89
تغییر روزانه
-1.01 -0.58%
ماهیانه
-1.02%
سالیانه
23.34%
Q2 پیش بینی
154.39




بدهی های جاری تغییر دادن تاریخ
Agilent USD 2.23B 113M 2025-12
Align Technology USD 1.92B 46.45M 2025-12
Bio-Rad Laboratories USD 517M 5.3M 2025-12
Bruker USD 1.28B 11.1M 2025-12
Cardinal Health USD 43.31B 3.05B 2025-12
Charles River Laboratories USD 1.12B 1.57M 2025-12
Cigna USD 56.34B 111M 2025-12
Concord Medical Services Hldg CNY 2.45B 1.12B 2025-06
CVS Health USD 88.69B 4B 2025-12
Danaher USD 6.81B 483M 2025-12
Dentsply International USD 1.34B 62M 2025-12
Elevance Health USD 41.04B 157M 2025-12
Galapagos EUR 152.86M 213.7M 2025-12
Hologic USD 951.3M 25.9M 2025-12
Humana USD 16.35B 166M 2025-12
Illumina USD 1.59B 377M 2025-12
Incyte USD 1.52B 176.44M 2025-12
Intrexon USD 23.02M 38K 2024-06
IQVIA Holdings USD 8.34B 170M 2025-12
Laboratory Of America USD 2.82B 194.3M 2025-12
Lonza CHF 3.57B 421M 2025-12
McKesson USD 68.13B 100M 2025-12
Merck EUR 9.04B 405M 2025-12
Mettler Toledo International USD 1.2B 5.99M 2025-12
Novartis USD 27.28B 4.72B 2025-12
Pfizer USD 36.6B 1.13B 2025-09
Quest Diagnostics USD 2.28B 144M 2025-12
Revvity USD 1.33B 108.5M 2025-12
Thermo Fisher Scientific USD 15.19B 301M 2025-12
United Therapeutics USD 560.6M 14.3M 2025-12
UnitedHealth USD 115.53B 4.74B 2025-09
Veradigm USD 230.31M 22.78M 2022-12
Waters USD 1.24B 11.8M 2025-12
West Pharmaceutical Services USD 654.9M 19.5M 2025-12